ReviewPharmacoEconomics2008
Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.
Björn Wettermark et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it
ReviewPharmacoEconomics2008
Björn Wettermark et al.PubMed ↗Publisher ↗
No numbers read from the abstract.